• Medical_Professionals
• Medical_students
• Nurses
• Exhibitors
• Press

• Certificate_of_Attendance
• Letter_of_Invitation_Provided
• Proof_of_Residency_Needed
• Badges_Provided
• No_Smoking
• Speakers_ready_room

More Info

Dear Colleagues,

 will be held in Prague, Czech Republic, September 3-6, 2015.

The 2nd edition of this ‘concept meeting’ will continue to focus on therapeutic issues of neurological diseases, including Multiple Sclerosis, Parkinson’s Disease, Stroke, and Alzheimer’s Disease. Despite the false perception that neurology deals with untreatable conditions, neurological practice is constantly undergoing dramatic changes, and numerous drugs and other forms of therapy continue to emerge. Their integration into common practice is associated with controversies and dilemmas which will be spotlighted at this congress.Likewise, innovations and future trends in therapy will be presented.

The format of debates and discussions, allowing ample time for speakers-participants interactive communication, will provide clinicians with insights and take-home messages to improve treatment in difficult situations.

We look forward to your participation and contribution in the 2nd World Congress on NeuroTherapeutics: Dilemmas, Debates & Discussions (DDDN) and to welcoming you to the beautiful and historic city of Prague.

Sincerely,

Prof. Zohar Argov	Prof. Israel Steiner
Congress Chairpersons

Use the online registration system to register for 2nd World Congress on NeuroTherapeutics (DDDN) Dilemmas, Debates, Discussions.

EUR

More Info:

Accompanying persons not allowed

Monday, June 8, 2015 

Abstract Submission will be available shortly  

Each submitter can present up to 2 abstracts (only 1 of which can be an oral presentation).

Creation of a user account is required for the submission of an abstract.

Accepted abstract presenters must register and pay their registration fees by the deadline date noted in the letter of acceptance.  If payment is not received by the deadline date (or is received after the deadline date), the abstract(s) will be automatically withdrawn and will not appear in the Program or Abstract Book.

The Scientific Committee may request pre-registration from abstract submitters prior to abstract review.

After submission

• Any change of the presenting author needs to be communicated in the form of a written statement to the Scientific Committee.
• If the original presenting author is unable to present the abstract, it is that person's responsibility to ensure that one of the co-authors takes over this role.
• It is the duty of the original presenting author to advise CongressMed in writing of his successor’s full name and email address.
• If you want to withdraw your abstract, a written request to the DDDN Secretariat no later than July 15, 2015.

If you are registered, You can upload your abstract here or through you Account by adding this event to favorites

Submission Info

Monday, June 8, 2015 

Abstract Submission will be available shortly  

Each submitter can present up to 2 abstracts (only 1 of which can be an oral presentation).

Creation of a user account is required for the submission of an abstract.

Accepted abstract presenters must register and pay their registration fees by the deadline date noted in the letter of acceptance.  If payment is not received by the deadline date (or is received after the deadline date), the abstract(s) will be automatically withdrawn and will not appear in the Program or Abstract Book.

The Scientific Committee may request pre-registration from abstract submitters prior to abstract review.

After submission

• Any change of the presenting author needs to be communicated in the form of a written statement to the Scientific Committee.
• If the original presenting author is unable to present the abstract, it is that person's responsibility to ensure that one of the co-authors takes over this role.
• It is the duty of the original presenting author to advise CongressMed in writing of his successor’s full name and email address.
• If you want to withdraw your abstract, a written request to the DDDN Secretariat no later than July 15, 2015.

Writing an Abstract

The presenting author should present a case or a series of cases, highlighting treatment dilemmas which will be discussed by an expert panel.

Abstracts should be submitted in English and contain no more than 3,600 characters, including titles, graphs and non-visible characters, such as spaces and line breaks. 
Please write concisely and clearly and follow this structure:

1. Problem statement: Why do we care about the problem?
2. Methods: What did you actually do to get your results?
3. Results: What did you learn/invent/create?
4. Conclusion: What are the implications of your findings?

 Please ensure that your abstract does not contain spelling, grammar or scientific mistakes, as it will be reproduced exactly as submitted. No proof reading will be done. Linguistic accuracy is the responsibility of the submitter. 
An abstract cannot be accepted if the conflict of interest disclosure is not signed.

Abstracts must contain data and meet international ethical standards.

Abbreviations should be defined.

Images can be uploaded according to the following criteria: 
Width (in pixels): min 50 / max 750

• Height (in pixels): min 50 / max 750
• Size (in KB): min 40/ max 1,000
• DPI: min 96 / max 300
• Format: JPG or GIF

 Tables can be inserted in the conclusion according to the following rules:

• Maximum number of table: 2
• Minimum number of rows: 1
• Maximum number of rows: 15
• Minimum number of columns: 1
• Maximum number of columns: 10

 Abstract submissions that do not meet the above noted guidelines may be rejected without review.
The Scientific Committee may request additional information about abstracts and reject abstracts.